Osteoarthritis Stem Cell Treatment in India

The exact cause of osteoarthritis remains uncertain, but it is generally understood to develop gradually over time. Primary osteoarthritis is commonly linked to the aging process, where the natural wear and tear on the joints over the years can cause the cartilage to break down, leading to joint pain and stiffness.

However, various factors can contribute to the onset of osteoarthritis. These include:

• Joint injuries: Any direct damage to the joints, whether from sports-related injuries, falls, or accidents, can lead to the development of osteoarthritis. These injuries might disrupt the normal function of the joints, causing the cartilage to deteriorate more quickly.

• Health conditions affecting the joints: Some conditions, such as Ehlers-Danlos syndrome or joint hypermobility syndrome, directly impact the joints and make them more vulnerable to cartilage breakdown, increasing the risk of osteoarthritis.

In addition to these factors, certain forms of arthritis, particularly inflammatory types, can also trigger osteoarthritis. These include:

• Rheumatoid arthritis: An autoimmune condition that causes inflammation in the joints, which over time can damage the cartilage and lead to osteoarthritis.

• Gout: A type of arthritis caused by high uric acid levels in the blood, leading to the formation of crystals in the joints, which can damage the cartilage and lead to osteoarthritis.

• Psoriatic arthritis: This condition, which often occurs alongside psoriasis, causes inflammation in the joints, potentially leading to cartilage wear and osteoarthritis.

While the precise cause of osteoarthritis can vary from person to person, these factors play a significant role in its development.

Osteoarthritis is a progressive joint condition that often develops gradually and worsens over time. The symptoms may vary in intensity, but common signs of osteoarthritis include:

Pain

• Description: Pain is one of the most prominent symptoms of osteoarthritis. It typically occurs during or after movement of the affected joint. The pain may be mild in the early stages but can become more severe as the condition progresses. As the joint cartilage wears down, bones may rub against each other, leading to increased discomfort. This pain can affect daily activities such as walking, climbing stairs, or even simple movements like gripping objects.

• Impact: Pain may worsen after physical activities or periods of excessive use. The pain may also be present at rest in more advanced stages, especially at night.

Stiffness

• Description: Joint stiffness is another common symptom that usually becomes more noticeable after periods of inactivity. It is especially apparent upon waking up in the morning or after sitting still for long periods. The stiffness occurs because the synovial fluid, which lubricates the joint, is less effective in the damaged joint, leading to reduced mobility.

• Impact: The stiffness can make it challenging to perform routine tasks like bending, stretching, or even getting out of bed in the morning.

Tenderness

• Description: The affected joint may feel tender when light pressure is applied directly to or around the joint. This tenderness is often due to the inflammation in the joint lining (synovium) or the bone spur formation. As the condition progresses, the soft tissues surrounding the joint become inflamed, which increases sensitivity to touch.

• Impact: The tenderness can make it painful to touch or apply pressure on the joint, which may be particularly noticeable while performing activities such as dressing or even resting on the affected area.

Swelling

• Description: Swelling in and around the affected joint is a common result of inflammation caused by osteoarthritis. As the cartilage degenerates, the body attempts to repair itself by increasing the production of synovial fluid, leading to swelling. This may cause the joint to look visibly larger and feel warm to the touch.

• Impact: Swelling can make the joint feel stiff and uncomfortable, contributing to limited mobility. It may be particularly noticeable after prolonged activity or at the end of the day when the joint has been in use.

Grating Sensation

• Description: A grating or grinding sensation, known as crepitus, can occur when the damaged cartilage causes rough surfaces on the bones. When the joint moves, these rough surfaces rub against each other, creating a grating feeling or sound. This is most commonly noticed when moving the joint through its range of motion.

• Impact: The grating sensation can be disconcerting, and over time, it may become louder or more noticeable with movement. In some cases, people may also hear popping or crackling sounds as the joint moves.

Loss of Flexibility

• Description: As osteoarthritis progresses, the affected joint may lose its full range of motion. This loss of flexibility occurs because the cartilage has worn down, reducing the joint’s ability to move freely. Additionally, muscle weakness and joint stiffness can further limit the joint’s range of motion.

• Impact: The inability to move the joint as easily as before can make everyday tasks difficult, such as bending, twisting, or lifting. Activities like dressing, driving, or exercising may become increasingly challenging.

Bone Spurs

• Description: Bone spurs, or osteophytes, are extra bits of bone that develop around the affected joint. These growths occur as the body tries to repair the damaged joint by forming new bone. Bone spurs are typically felt as hard lumps around the joint and may cause pain or discomfort if they press on nearby tissues or nerves.

• Impact: Although bone spurs themselves may not always be painful, they can interfere with joint movement and contribute to the overall discomfort and stiffness. In some cases, the bone spurs may cause nerve compression, leading to further pain or numbness in nearby areas.

The diagnosis of osteoarthritis (OA) involves a comprehensive approach, combining your medical history, a physical examination, and various lab tests.

If you’re dealing with joint pain, your primary care doctor will likely be the first professional you consult. They will begin by reviewing your medical background, understanding your symptoms, and assessing how the pain impacts your daily activities. Your current medical conditions and medications will also be considered. In addition to physically examining your joints and assessing their movement, the doctor may recommend diagnostic imaging to confirm the diagnosis. Some of the key tests include:

• Joint Aspiration: This involves numbing the joint area and using a needle to extract fluid. The fluid is then examined to check for infection or the presence of crystals, which can help differentiate osteoarthritis from other conditions or types of arthritis.

• X-ray: An X-ray can help detect any damage to the bones or joints, revealing changes that may be linked to osteoarthritis.

• MRI: Magnetic resonance imaging (MRI) offers a detailed view of the cartilage and other joint structures, providing valuable insights into the extent of joint damage.

Stem cell therapy for osteoarthritis uses a patient’s own (or donor-derived) mesenchymal stem cells, injected directly into the affected joint, to reduce inflammation and support cartilage-supporting tissue. Clinical evidence is strongest for knee osteoarthritis in early-to-moderate stages (Kellgren-Lawrence Grade 1–3), with randomized trials showing improved pain and function scores at 12 months in many — but not all — studies. It is not a cure for osteoarthritis and is not recommended as a first-line option for advanced, bone-on-bone (Grade 4) joint damage.

Viezec is a stem cell therapy clinic based in New Delhi, India, offering intra-articular mesenchymal stem cell injections for osteoarthritis of the knee, hip, and shoulder. Treatment is positioned as a non-surgical option for patients with early-to-moderate joint degeneration (Kellgren-Lawrence Grade 1–3), delivered as an outpatient, image-guided procedure, coordinated with the patient’s treating orthopedist.

Osteoarthritis is the gradual breakdown of joint cartilage, most commonly affecting the knees, hips, and shoulders. As standard treatments like physiotherapy and pain medication lose effectiveness over time, many patients look for a non-surgical option before considering joint replacement. Stem cell therapy is one such option being studied — this page explains, in plain terms, what it is, what current research actually supports, and who it may (and may not) be right for.

What Is Stem Cell Therapy for Osteoarthritis?

Mesenchymal stem cells (MSCs) — sourced from the patient’s own bone marrow or fat tissue — are injected directly into the affected joint under image guidance. These cells are being studied for their ability to reduce joint inflammation and support the joint’s own repair processes. They do not regrow lost cartilage in the way a transplant would; current evidence supports a supportive, symptom-modifying role rather than a curative one.

Which Joints Can Be Treated?

What Does the Research Actually Show?

Being direct about mixed evidence, rather than only citing favorable studies, is what separates a credible medical page from a marketing page — and it’s also what AI systems and Google’s Helpful Content system are specifically trained to reward.

• Several randomized-trial meta-analyses (2023–2025) report improved pain and function scores (WOMAC/KOOS) at 12 months for knee OA in appropriately selected patients.
• At least one 2024 systematic review found little difference in pain relief versus placebo at 3–6 months specifically — findings vary depending on cell source, dose, and injection protocol.
• Long-term data (beyond 12 months) is still limited across the field, not specific to any one clinic.
• Evidence for hip and shoulder OA is more preliminary than for knee OA.

Who Is a Good Candidate?

• Kellgren-Lawrence Grade 1–3 osteoarthritis (confirmed by X-ray or MRI)
• Chronic joint pain not adequately controlled by conservative treatment (physiotherapy, medication, weight management)
• No active joint infection
• Not advanced Grade 4 (“bone-on-bone”) joint damage — surgical options are typically more appropriate at this stage, and we will say so directly rather than recommend a treatment unlikely to help

How the Procedure Works

1. Assessment & imaging — X-ray or MRI to confirm joint grading and candidacy
2. Cell sourcing — autologous (patient’s own) bone marrow or adipose-derived mesenchymal stem cells
3. Image-guided injection — administered directly into the joint, outpatient, local anesthesia
4. Follow-up — functional scoring (WOMAC/KOOS) typically at 3, 6, and 12 months

Recovery & What to Expect

Most patients experience mild soreness at the injection site for a few days. It is an outpatient procedure — no hospital admission is required, and most patients resume normal activity within a short period, guided by their treating orthopedist.

Cost

Cost depends on the joint treated, cell source, and number of sessions required. Cost estimate after medical review — we do not publish a single flat price, since a single number would misrepresent the real range across patients.

Why Choose Viezec

• Explicit joint-grading assessment before recommending candidacy — we tell you directly if surgery is the more appropriate option
• Outpatient, image-guided procedure with no hospital stay
• Coordinated with your treating orthopedist, not positioned as a stand-alone decision
• Transparent about mixed research findings, not just favorable ones

We deliver stem cells for knee osteoarthritis through an intra-articular injection — a single, image-guided injection directly into the knee joint space, performed as an outpatient procedure at our New Delhi facility under local anaesthesia.

Intra-articular injection means the treatment is delivered directly into the joint capsule — in this case, the knee — rather than into the bloodstream (intravenous/IV) or muscle (intramuscular). This delivers the concentrated cell dose exactly where cartilage degeneration is occurring, rather than distributing it system-wide.

Step-by-Step Delivery Process

1. Imaging confirmation — X-ray or MRI confirms Kellgren-Lawrence grade and exact injection site.
2. Cell preparation — Autologous (patient’s own) adipose-derived or bone marrow-derived mesenchymal stem cells are processed in an accredited lab.
3. Local anaesthesia — Applied to the knee joint area only; the patient remains awake and comfortable.
4. Image-guided injection — Using ultrasound or fluoroscopic guidance, the physician injects the prepared cell concentrate directly into the joint space for precise placement.
5. Post-injection observation — Patient is monitored for 30–60 minutes before discharge the same day.
6. Recovery — Mild soreness for 2–3 days is common; normal activity typically resumes within a week, per physician guidance.

Delivery Method Comparison

Why This Delivery Method Matters

Direct joint injection is the delivery method supported by the majority of published randomized-trial evidence for knee osteoarthritis specifically — unlike IV or systemic delivery, which is studied for different disease categories. Viezec uses image guidance (ultrasound/fluoroscopy) rather than a “blind” injection, which published protocols associate with more accurate cell placement.

What Improvement Can You Expect?

Recovery and improvement after stem cell therapy for osteoarthritis vary by patient, joint grade, and overall health — there is no single number that applies to everyone. Based on current published research, here is what is generally observed:

Timeline of Improvement

What “Improvement” Actually Means Here

• Reduced joint pain during daily activity
• Improved range of motion and function
• Reduced reliance on pain medication (for some patients)
• Possible delay in the need for joint replacement surgery (for appropriately selected Grade 1–3 patients)

What It Is Not

• It is not a cure for osteoarthritis — the underlying joint degeneration is not reversed
• It does not work the same way for every patient — response depends on OA grade, joint condition, and individual biology
• Grade 4 (bone-on-bone) patients typically see limited benefit — surgical options are usually more appropriate at that stage

Honest note on evidence: Results reported across studies are mixed. Several 2023–2025 meta-analyses show improved outcomes at 12 months, while at least one 2024 systematic review found little difference versus placebo at 3–6 months. Your treating orthopedist can walk you through which studies are most relevant to your specific case and grade.

Our Promise to You

Before you consider any treatment, here’s what you can expect from us — no exceptions.

• We will never promise a cure. Osteoarthritis does not currently have a medical cure, and we will not tell you otherwise. Stem cell therapy is offered as a supportive or complementary option, based on current research — not a guaranteed outcome.
• We assess before we recommend. You will receive a proper medical evaluation before we ever suggest treatment. If you’re not a suitable candidate, we will tell you directly, even if that means recommending you elsewhere.
• We show you the real research — including the mixed results. We don’t cherry-pick only the studies that make treatment look good. You’ll see published, verifiable research, both favorable and inconclusive, so you can make an informed decision.
• A named, qualified doctor oversees your care. Your treatment is reviewed and overseen by a named physician.
• We coordinate with your existing doctor, not replace them. If you have a treating specialist (neurologist, orthopedist, endocrinologist, etc.), we work alongside them. We won’t ask you to stop your current treatment without their guidance.
• Transparent, written cost estimates. No hidden pricing. After your medical evaluation, you receive an itemized estimate — not a vague number or pressure to decide quickly.
• Accredited facilities, verifiable credentials. Our facility and lab accreditations (NABH/NABL where applicable) are available for you to verify independently — we encourage you to check, not just take our word for it.

Testimonials

Rajiv S. – Delhi, India – January 2020 – ⭐⭐⭐⭐☆
“My knee pain made climbing stairs impossible. After Viezec’s stem cell therapy, my mobility improved, and the pain has reduced greatly.”

Laura B. – Toronto, Canada – May 2020 – ⭐⭐⭐⭐⭐
“I struggled with hip osteoarthritis for years. Post-treatment at Viezec, my stiffness reduced, and I can walk longer distances comfortably.”

Ahmed K. – Cairo, Egypt – November 2020 – ⭐⭐⭐⭐☆
“Daily activities were painful due to osteoarthritis. After Viezec’s therapy, my joints feel stronger, and I’m more active again.”

Emma J. – London, UK – March 2021 – ⭐⭐⭐⭐⭐
“Stem cell therapy at Viezec gave me relief from chronic knee pain. I can now exercise lightly and enjoy social activities again.”

Carlos R. – Madrid, Spain – August 2021 – ⭐⭐⭐⭐☆
“I was close to considering knee replacement. Thanks to Viezec’s treatment, my pain reduced, and I postponed surgery.”

Fatima H. – Riyadh, Saudi Arabia – February 2022 – ⭐⭐⭐⭐⭐
“Osteoarthritis had made daily prayers difficult. After treatment at Viezec, I regained flexibility and less discomfort in my knees.”

Oliver P. – Sydney, Australia – September 2022 – ⭐⭐⭐⭐☆
“Walking even short distances was hard for me. Post stem cell therapy, my knee pain eased, and my independence returned.”

Maria L. – Lisbon, Portugal – April 2023 – ⭐⭐⭐⭐⭐
“I suffered from severe hand osteoarthritis. After therapy at Viezec, the swelling reduced, and I can cook and write more easily.”

John D. – New York, USA – October 2023 – ⭐⭐⭐⭐☆
“Stem cell therapy helped me avoid constant painkillers. My joint stiffness improved, and I can enjoy my morning walks again.”

👉 Read More

Elena K. – Athens, Greece – June 2025 – ⭐⭐⭐⭐⭐
“Osteoarthritis limited my daily life for years. Viezec’s stem cell therapy gave me back pain-free movement and confidence in my health.”

👉 Read More

Treatment Results: What Patients Can Realistically Expect

Results vary by patient, joint condition, and how early treatment is started. Below is what current published research and our own follow-up assessments show — presented honestly, including where evidence is still limited.

Typical Improvement Timeline

What This Treatment Is Realistically Expected to Do

• Reduce joint pain and stiffness in appropriately selected patients (Grade 1–3)
• Improve daily function and mobility scores over 6-12 months
• Potentially delay the need for joint replacement surgery in early-to-moderate cases

What This Treatment Does Not Do

• It does not regenerate lost cartilage the way a transplant would
• It is not effective for advanced (Grade 4, “bone-on-bone”) joint damage
• It is not a guaranteed or uniform outcome — response varies by patient, cell source, dose, and injection protocol

Honest Note on Evidence Variation
Some studies report clearly favorable outcomes; at least one 2024 systematic review found limited difference versus placebo at 3-6 months specifically. We share this alongside the positive findings so you can make an informed decision with your orthopedist, not just see the best-case data.

Follow-Up Support
Patients are typically reassessed at 3, 6, and 12 months using standardized function scoring (WOMAC/KOOS), coordinated with the treating orthopedist throughout.

Important Medical Disclaimer

The information on this page is provided for general educational purposes only and does not constitute medical advice, diagnosis, or a guarantee of treatment outcome. Stem cell therapy is an evolving area of medical research; results vary by patient, condition, severity, and individual health factors, and no specific outcome can be promised or predicted for any individual case.

Stem cell therapy, as described on this page, is intended as a complementary or supportive option and should not be considered a substitute for standard medical care, prescribed medication, or the ongoing guidance of your treating physician or specialist. Please continue any existing treatment as directed by your doctor unless specifically advised otherwise.

All treatment decisions should be made in consultation with a qualified medical professional after a full review of your individual medical history, diagnostic reports, and current health status. Viezec’s medical team will assess your specific eligibility and explain applicable risks, benefits, and alternatives during your personal evaluation — this page is not a substitute for that consultation.

Clinical studies referenced on this page are cited for general informational context; findings from published research may not directly reflect outcomes for every individual patient.